1 | LMIC’s* |
2 | Exercise (MeSH Terms) OR ‘Physical Exercise’ (tw) OR ‘Physical activity’ (tw) |
3 | (‘Weight Loss/classification’(Mesh) OR ‘Weight Loss/complications’(Mesh) OR ‘Weight Loss/diagnosis’(Mesh) OR ‘Weight Loss/diet therapy’(Mesh) OR ‘Weight Loss/drug effects’(Mesh) OR ‘Weight Loss/drug therapy’(Mesh) OR ‘Weight Loss/epidemiology’(Mesh) OR ‘Weight Loss/etiology’(Mesh) OR ‘Weight Loss/genetics’(Mesh) OR ‘Weight Loss/metabolism’(Mesh) OR ‘Weight Loss/mortality’(Mesh) OR ‘Weight Loss/prevention and control’(Mesh) OR ‘Weight Loss/rehabilitation’(Mesh) OR ‘Weight Loss/statistics and numerical data’(Mesh)) |
4 | Exercise therapy (mesh) OR Exercise test (mesh OR Exercise Movement Techniques (mesh) |
5 | ‘weight loss’ (tw) OR weight reduction programme (MeSH Terms) OR ‘weight reduction’ (tw) OR losing weight (tw) |
6 | ‘Sodium restriction’ (tw) OR Dietary potassium (MeSH Terms) OR ‘Dietary potassium’ (tw) OR ‘Calcium supplementation’ OR ‘Fish oil supplementation’ (tw) |
7 | Salt Restrict*(tiab) OR low Sodium*(tiab) OR low salt*(tiab) OR Potassium, Diet* (tw) |
8 | Magnesium (tw) OR Calcium (tw) |
9 | ‘Salt intake’ (tw) OR Sodium Chloride, Dietary (MeSH Term) OR ‘Dietary salt’ (tw) OR ‘Dietary Salt intake’ (tw) OR ‘Dietary Salt restriction’ (tw) |
10 | Garlic (MeSH Terms) OR Garlic (tw) |
11 | Smoking Cessation (MeSH Term) OR ‘Smoking Cessation’ (tw) OR Tobacco Use Cessation*(tw) |
12 | decreased (tw) AND (‘alcohol drinking’(MeSH Terms) OR (‘alcohol’(tw) AND ‘drinking’(tw)) OR ‘alcohol drinking’(tw) OR (‘alcohol’(tw) AND ‘intake’(tw)) OR ‘alcohol intake’(tw)) |
13 | Alcohol Drink*(tw) OR Alcohol consum*(tw) OR Drinking Alcohol*(tw) OR Alcoholi*(tw) OR non pharmacol*(tw) |
14 | life style*(tw) OR lifestyl*(tw) OR diet therapy (mesh) OR fat Restrict*(tiab) OR low fat*(tiab) OR Carbohydrate Restrict*(tiab)) OR low carb*(tiab) OR Caloric Restrict*(tw) OR Food, Formulated (tw) OR Formulated Food*(tw) OR diet (tw) OR dietary (tw) |
15 | Disease Management*(tw) OR kinesiotherap*(tw) OR Physical Endurance (mesh) OR Anaerobic*(tiab) OR aerobic*(tiab) OR Resistance Training*(tiab) OR Motor activit*(tw) OR Physical Activit*(tiab) OR Locomotor Activit*(tiab) |
16 | Social support*(tw) OR Social Network*(tiab) OR relaxation therap* (tw) OR tai-chi (tw) OR yoga (tw) |
17 | OR/2–16 |
18 | ‘Hypertension/classification’(Majr) OR ‘Hypertension/complications’(Majr)) OR ‘Hypertension/diet therapy’((Majr) OR ‘Hypertension/drug effects’(Majr) OR ‘Blood Pressure/classification’(Mesh) OR ‘Blood Pressure/complications’((Mesh) OR ‘Blood Pressure/diagnosis’(Mesh) OR ‘Blood Pressure/drug effects’(Mesh)) OR ‘Blood Pressure/etiology’(Mesh) OR ‘Blood Pressure/genetics’(Mesh) OR ‘Blood Pressure/metabolism’(Mesh) OR ‘Blood Pressure/methods’(Mesh) OR ‘Blood Pressure/statistics and numerical data’(Mesh) OR ‘Blood Pressure/therapy’(Mesh) ‘Hypertension/drug therapy’(Majr) OR ‘Hypertension/epidemiology’(Majr) OR ‘Hypertension/etiology’(Majr) OR ‘Hypertension/genetics’(Majr) OR ‘Hypertension/metabolism’(Majr) OR ‘Hypertension/mortality’(Majr) |
19 | ‘Hypertension/prevention and control’(Majr) OR ‘Hypertension/rehabilitation’(Majr) OR ‘Hypertension/therapy’(Majr) OR ‘Blood Pressure/classification’(Mesh) OR ‘Blood Pressure/complications’(Mesh) OR ‘Blood Pressure/diagnosis’(Mesh) OR ‘Blood Pressure/drug effects’(Mesh) OR ‘high blood pressure’ (tw) OR ‘Blood pressure’ (tw) OR bloodpressure (tw) OR (‘Systole/drug effects’(Majr) OR ‘Systole/etiology’(Majr) OR ‘Systole/genetics’(Majr)) OR ‘Blood Pressure/etiology’(Mesh) OR ‘Blood Pressure/genetics’(Mesh) OR ‘Blood Pressure/metabolism’(Mesh) OR ‘Blood Pressure/methods’(Mesh) OR ‘Blood Pressure/statistics and numerical data’(Mesh) OR ‘Blood Pressure/therapy’(Mesh) OR ‘high blood pressure’ (tw) OR ‘Blood pressure’ (tw) OR bloodpressure (tw) OR (‘Systole/drug effects’(Majr) OR ‘Systole/etiology’(Majr) OR ‘Systole/genetics’(Majr)) OR (‘Diastole/drug effects’(Mesh) OR ‘Diastole/etiology’(Mesh) OR ‘Diastole/genetics’(Mesh)) OR ((arterial OR diastolic OR systolic) AND pressure) OR Hypertension (tw) OR ‘Blood Pressure’ (tw) |
20 | OR/18–19 |
21 | Randomised controlled trial (tiab) OR controlled clinical trial (tiab) OR randomised (tiab) OR placebo (tiab) OR randomisation (tiab) OR randomisation (tiab) OR drug therapy (tiab) OR randomly (tiab) OR trial (tiab) OR groups (tiab) |
22 | #1 AND #17 AND #20 AND #21 |
23 | animals (mh) NOT humans (mh) |
24 | #22 NOT #23 |
25 | Restrict #24 to year=1990 and up to date |
26 | Restrict #25 to English language |
27 | Restrict #26 to Age 18+years |
*Search terms and search strategy for LMICs are provided in online supplementary file 2.
LMICs, low-income middle-income countries.